Molecular Conferences | Molecular Medicine Conference | Molecular Diagnostics Conference | Molecular Pathology Conferences | Experimental and Molecular Medicine | Molecular biology Conference 2018 | Asia Pacific | Dubai | Europe | USA | Spain | UAE

Theme: Exploring the Modern Innovations in the Field of Molecular Medicine and Diagnostics

Molecular Medicine 2018

Renowned Speakers

Jan Oxholm Gordeladze
University of Oslo
Norway

Martin Fluck
Professor University Hospital Balgrist, Switzerland
Switzerland

Jianhua Luo
University of Pittsburgh School of Medicine, USA
USA

Michael E Sughrue
University of Oklahoma, USA
USA

Arvind Chhabra
University of Connecticut Health Center, USA
USA

Dana L Abramovitz
SXSW LLC, USA
USA

Louise S Mackenzie
University of Hertfordshire, UK
UK

Tanima Banerjee
CSIR-Indian Institute of Chemical Biology, India
India

Masahide Takahashi
Nagoya University Graduate School of Medicine, Japan
Japan

Rajaa Fakhoury
Beirut Arab University, Lebanon
Lebanon

Susruta Sen
The Calcutta Medical Research Institute, India
India

Margaret A Wheatley
Drexel University, USA
USA

Arkady Mustaev
State University of New Jersey, USA
USA

Peter L Nagy
Columbia University Medical Center, USA
USA

Marisa Martin-Fernandez
Rutherford Appleton Laboratory, UK
UK

Vladislav S Baranov
Ottâ€™s Institute of Obstetrics, Russian Federation
Russia

Yeng S Ang
University of Manchester, UK
UK

Muying Ying
Nanchang University, China
China

Jurgen Dittmer
Martin Luther University, Germany
Germany

Janak Kishore
Sanjay Gandhi Post-Graduate Institute of Medical Sciences, India
India

Ya-Ching Lu
Chang Gung University, Taiwan
Taiwan

Ryou-u Takahashi
National Cancer Center Research Institute, Japan
Japan

Vimal Karani S
University of Reading, UK
UK

Li Wang
Capital Institute of Pediatrics, China
China

Evguenia Alechine
University of Buenos Aires, Argentina
Argentina

Ashwani Kumar
Sant Longowal Institute of Engineering and Technology, India
India

Raj Kumar
Sant Longowal Institute of Engineering and Technology, India
India

Toru Kondo
Hokkaido University, Japan
Japan

Joseph Irudayaraj
Purdue University USA
USA

Rasime Kalkan
Near East University Turkey
Turkey

Karim Nayernia
Erciyes University Turkey
Turkey

Thomas Boyd
University of Texas USA
USA

Alexzander Asea
Morehouse School of Medicine Saudi Arabia
Saudi Arabia

Peter J van der Spek
Department of Head Bioinformatics at Erasmus MC Netherlands
Netherlands

Subrata Majumder
University of Calcutta India
India

Sean X Hu
Global Data, USA
USA

Howard R. Moskowitz
Mind Genomics Advisors, LLC, Saratoga Springs, NY
USA

Vincent S.Gallicchio
Clemson University USA
USA

Bahram G Kermani
Crystal Genetics Inc.,USA
USA

David Duggan
Translational Genomics Research Institute, USA
USA

Oscar Teijido
Camilo JosÃ© Cela University, Spain
Spain

Anthony Johnson
Empire Genomics LLC, USA
USA

RamÃ³n Cacabelos
Camilo JosÃ© Cela University, Madrid, Spain.
Spain

Hiroyuki A Watanabe
Showa University Northern Yokohama Hospital, Japan
Japan

Gargi Basu
Ashion Analytics, USA
USA

Candida Fratazzi
BBCR Consulting, Cambridge, MA
USA

Ahmed El-Tahtawy
Pfizer Inc, USA
USA

Gauri Naik
Optra Systems Inc, USA
USA

Naveen Kumar Kaushik
Amity University Noida, UP, India
India

Lars von Olleschik-Elbheim
Consultant and project manager, Berlin
Germany

Seyedeh Afrooz Azimi
Mashhad University School of Medicine, Mashhad, IRAN
Iran

Shahla Masood
University of Florida, USA
USA

Dale D Tang
Albany Medical College, USA
USA

Robert H Schiestl
University of California, USA
USA

Sheng Xi Chen
Arizona State University, USA
USA

Mark Podberezin
University of Saskatchewan, Canada
Canada

Yaping Tian
Chinese PLA General Hospital, China
China

Dipak P Ramji
Cardiff University, United Kingdom
UK

Kunlun He
Chinese PLA General Hospital, China
China

Malgorzata Jaremko
Phosphorus Diagnostics, USA
USA

Molecular Medicine 2018

“3^rd International Conference on Molecular Medicine and Diagnostics” schedules on April 19-20 of 2018, at Dubai UAE.

Molecular Medicine 2018 theming “Exploring the modern Innovations in the field of Molecular Medicine and Diagnostics” provides a distinguished platform for all the Participants around the globe to enlighten the subject and the developments.

ME Conferences invites all the delegates across the world to take part in the conference and make the way for a successful conference. Molecular Medicine 2018 mainly focuses on the developing trends and advances in the field of Molecular & Cellular Medicine and Biochemistry.

“3rd International Conference on Molecular Medicine and Diagnostics” provides a valuable platform to discuss and learn about Molecular Medicine, Biochemistry, Cancer Immunology and Oncology, Advanced Gene Therapeutics, Current advances and Clinical aspect of Molecular Medicine, Cellular Medicine, Cell and Gene Therapy, Pathology and Molecular Medicine, Nanotechnology, Cancer and Stem Cells, Stem Cell Treatment, Stem Cell Biology, Recent Trends in Cell Biology of Aging, Molecular medicine and Personalized Healthcare, Advanced Molecular Diagnostics. Molecular Medicine 2018 is given to the headway and spread of new learning about all viewpoints under Molecular Medicine & Biochemistry.

Track 1: Molecular Medicine

Molecular Medicine currently focused on the Cancer Biology, Infectious Diseases and Neural/Sensory Biology. These are underpinned by cutting-edge human pluripotent stem cell and regenerative medicine expertise and provides access to normal and diseased human cell types for more relevant investigations. Cancer. Biology theme is mainly focused on common cancers that affect our community: breast, prostate, head & neck, and skin cancers. molecular mechanisms and cellular processes in the main development and process of above cancers. Other, the Infectious Diseases it involves investigating the epidemiology of methicillin resistant Staphylococcus aureus in both the community and hospital environment. It includes understanding the molecular mechanisms that contribute to the capacity of staphylococcal plasmids to acquire. The last Neural/Sensory Biology, it concentrates on using a diverse range of techniques and models to address the key questions relating to neural and vision disorders. drug targets and cell and molecular mechanisms are key elements for making significant breakthroughs in neurodegenerative and blinding diseases.

10^th International Congress on Clinical Virology December 4-5, 2017 Dubai, UAE, Medical and Pharmaceutical Chemistry Conference July 19-21, 2018 Dubai, UAE, World Bio Summit & Expo December 11-12, 2017 Dubai, UAE , International Conference on Biomarkers and Cancer Targets July 16-17, 2018 Dubai, UAE , 11^th Annual Conference on Stem Cell and Regenerative Medicine July 19-20, 2018 Dubai, UAE World Congress on Stem Cell Biology and Biobanking August 20-21, 2018 Tokyo, Japan, International Conference on Tissue Science and Regenerative Medicine July 19-20, 2018 Melbourne, Australia, 7^th International Conference and Exhibition on Cell and Gene Therapy March 15-17, 2018 London, UK, 11^th World Congress on Cell & Tissue Science May 14-15, 2018 Tokyo, Japan8^th World Congress on Genomics Conferences July 9-10, 2018 Sydney, Australia, 9^th 3rd Annual Genome Editing & Engineering Conference on 8^th - 9^th February 2018 in San Diego, USA, Cell and Gene Therapy Innovation Leaders’ Summit, 7^th - 8^thFebruary 2018 Berlin, Germany, International Conference on Diagnostics in Electrical Engineering on September 04 - 07 2018, Pilsen, Czech Republic. International Conference on Diagnostic Pathology Update July 8- 13, 2018, Florence, Italy4^th International Conference on Synthetic Biology June 11-12, 2018 Rome, Italy, 9^th Clinical Microbiology Conference October 08-09, 2018 Zurich, Switzerland, International Conference on Diagnostics in Electrical Engineering on September 04 - 07 2018, Pilsen, Czech Republic.

Track 2: Molecular Biology

The Molecular Biology is the underpinnings of biological systems and pathways at multiple levels. current research efforts are mainly directed to Molecular basis of cell-cell communication in development, Structural basis for molecular interactions regulating autophagy, Structural basis for molecular interactions regulating necrotic cell death. Researchers in molecular biology utilize methods local to molecular biology however progressively consolidate these with systems and thoughts from genetical qualities and natural chemistry. Molecular biology is the investigation of molecular underpinnings of the procedures of replication, transcription, translation, and cell function. The focal doctrine of Molecular biology where Genetic material is transcribed into RNA and after that converted into protein, regardless of being oversimplified, still gives a decent beginning stage to understanding the field

Conference on Cancer Diagnostics November 27- 28, 2017 Dubai, UAE, 4^th World Congress on Human Genetics April 23-24, 2018 Dubai, UAE, 11^thWorld Microbiology Congress September 26-27, 2018 Dubai, UAE, 6^th Annual Congress on Biology and Medicine of Molecules September 20-21,2018 Kuala Lumpur, Malaysia14^thConference on Structural Biology September 24-26, 2018 Berlin, Germany, 20^th Global Congress on Biotechnology March 5-7, 2018 London, UK , 11^th World Congress on Plant Biotechnology & Agriculture, March 05-07, 2018 Paris, France, 3^rd Conference on Enzymology and Molecular Biology March 05-06, 2018 London, UK , 8^th Global Summit on Microbiology & Infectious Diseases February 22-23, 2018 Paris, France, International Conference on Diagnostics in Electrical Engineering on September 04-07, 2018, Pilsen, Czech Republic. International Conference on Diagnostic Pathology Update July 8- 13, 2018, Florence, Italy, Annual Summit on Cell Therapy and Molecular Medicine. Chicago, USA. September 27-28, 2017, 20th International Conference on Molecular Diagnostics, Zurich, Switzerland September 13 - 14, 2018, 8^th European Conference on Molecular Diagnostics August 20-21, 2018 Rome, Italy, 13^th International Conference on Medicine & Pathology March 05-06, 2018 Berlin, Germany, 4^th World Congress on Medical Imaging and Clinical Research, September 03-04, 2018 London, UK, International Conference on Diagnostic Pathology Update July 8- 13, 2018, Florence, Italy, Molecular Immunology & Immunogenetics Congress March 08-09, 2018 London, UK

Track 3: Molecular Pathology

Molecular pathology is a rising order inside pathology which is engaged in the investigation and finding of infection through the examination of particles inside organs, tissues or natural liquids. Molecular pathology imparts a few parts of training to both anatomic pathology and clinical pathology, molecular science, bio chemistry, proteomics and genetics, and is at times considered a "hybrid" teach. It is multi-disciplinary in nature and concentrates predominantly on the sub-microscopic parts of illness. A key thought is that more exact analysis is conceivable when the finding depends on both the morphologic changes in tissues and on molecular testing.

Track 4: Biochemistry

Biochemistry is the study of the structure and function of biological molecules such as proteins, nucleic acids, carbohydrates and lipids. Biochemistry is also used to describe techniques suited to understanding the interactions and functions of biological molecules and it is a laboratory based science that brings together biology and chemistry. By using chemical knowledge and techniques, biochemists can understand and solve biological problems. Biochemistry focuses on processes happening at a molecular level and it focuses on what’s happening inside our cells. It also looks at how cells communicate with each other, for example during growth or fighting illness.

Medicine is a broad category but relates to biochemistry on many levels. Doctors and nurses give drugs to patients to help cure a disease or prevent it. This is since when that drug is added to the human system, it alters how other chemicals in the body function, resulting in disease prevention or recovery.

Track 5: Molecular Biomarkers

Molecular Biomarker is a measurable indicator of the seriousness or presence of some disease state. Generally, for most part a biomarker is anything that can be utilized as a pointer of a specific disease state or some other physiological condition of a life form. DNA marker is the term used to allude to a DNA variety between people that has been observed to be related with a specific trademark. These diverse DNA or genetic variations are known as alleles. A genetic marker is utilized to distinguish people or species and to relate acquired illness. It can be portrayed as a variety that can be watched. A genetic marker is utilized to distinguish characteristics as well as to describe germ plasm.

Track 6: Molecular Drug Designing

Drug design, frequently alluded to as reasonable medication outline or essentially normal plan, is the innovative procedure of finding new pharmaceuticals considering the information of a natural target. The medication is most generally a natural little atom that actuates or restrains the capacity of a bio molecule. for example, a protein, which thus brings about a remedial advantage to the patient. In the most essential sense, medicate configuration includes the outline of particles that are corresponding fit as a fiddle and charge to the bio molecular focus with which they collaborate and in this way, will tie to it. Medication outline much of the time however not really depends on PC displaying systems.

Track 7: Molecular Modeling and Dynamics

Molecular dynamics (MD) is a computer simulation technique for concentrate the physical developments of atoms and molecules, and is along these lines a kind of N-body reenactment. The molecules and atoms are permitted to cooperate for a settled time, giving a perspective of the dynamic development of the framework. In the most widely recognized form, the directions of molecules and atoms are dictated by numerically explaining Newton's conditions of movement for an arrangement of cooperating atoms, where powers between the atoms and their potential energies are computed utilizing interatomic possibilities or molecular mechanics compel fields. The strategy was initially created inside the field of hypothetical physical science in the late 1950s yet is connected today generally in compound material science, materials science and the demonstrating of biomolecules.

Track 8: Molecular Virology

An effective immune response can eliminate most viruses from the body and thus most viral infections are short lived. However, there are certain viruses that can evade the immune response and establish persistent infections in their host. The most famous example of such a virus is HIV, but there are many others. Viruses use a variety of strategies to evade the immune system. overall, these persistent infections are asymptomatic and only manifest clinically if the patient becomes immuno-compromised.

Track 9: Molecular Genetics

Molecular genetics is a study of heredity and variation at the molecular level, particularly the mechanisms of hereditary transmission, and the variation of inherited characteristics among similar or related organisms. its focused on the flow and regulation of genetic information between DNA, RNA, and proteins. It contains sub-fields mainly genomics and proteomics. This influential area of bio science contributes significantly to expanding our understanding of biology and allows us to develop bespoke diagnosis, treatment and disease prevention for each patient based on their own genetic make-up. The techniques employed in molecular genetics include amplification, polymerase chain reaction, DNA cloning, DNA isolation, mRNA isolation. It is essential in understanding and treating genetic disorders and regarded as the most advanced field of genetics. Genetics is not made up of two sciences, one molecular and one non-molecular. Nevertheless, practicing biologists still use the term.

Track 10: Stem Cell & Regeneration

All multi cellular animals and plants rely on stem cells to grow from a single cell into an adult and it allow our bodies to build new tissue, such as new muscle when we exercise. It continuously replaces the many specialized cells in our body if they are worn out or damaged. Generally, all stem cells fall into three different groups-embryonic stem cells are pluripotent cells, which means they can differentiate into all the types of specialized cells in the body-Tissue stem cells can both self-renew and give rise to at least one more specialized cell type-Induced pluripotent stem (IPS) cells: These cells can be generated from adults, avoiding the ethical concerns associated with research using human embryos. Research in regenerative medicine is bringing fabulous advances in science, technology, health and medicine. These holds promise for improving methods of disease diagnosis and prevention, to the development of innovative treatments for injuries and illnesses

Track 11: Molecular Microbiology

Presently the Molecular Microbiology research focus on the bacterial cell cycle, transcription regulation, chromosome segregation and cell division. It Includes the Structure-function analysis of the NusA-RNA polymerase interaction, Exploitation of the interaction of initiation factor with RNA polymerase for new antibiotic development, Systems biology of the model Gram positive organism Bacillus subtilis, Bacterial chromosome repair mechanisms. It aims at understanding protein export, solute transport and cell division in micro-organisms. These processes take place at the cytoplasmic membrane of micro-organisms, and membrane biology.

Track 12: Nuclear Medicine & Molecular Imaging

Nuclear Medicine includes the field of Molecular imaging. It uses in very small amounts of radioactive materials (radio pharmaceuticals) to diagnose and treat disease. In nuclear medicine imaging, the radio pharmaceuticals are detected by special types of cameras that work with computers to provide very precise pictures of the area of the body being imaged. Nuclear medicine can also be used to treat certain types of cancer and other diseases. Nuclear Medicine and Molecular Imaging are unique because an external source of energy such as x-rays, magnetic fields or ultrasound waves is used to produce pictures of bone and soft tissue. In nuclear medicine and molecular imaging procedures, the energy source is introduced into the body, where it gets incorporated in a specific tissue, organ or process and is then detected by an external device to provide information on organ function and cellular activity. These two are playing an increasingly important role in patient care, medical research, and pharmaceutical development.

Track 13: Cell and Gene Therapy

Cell therapy includes a treatment in which cell material is infused into a living cell. For instance, T cells equipped for battling malignancy cells by means of cell-intervened invulnerability might be infused over the span of immunotherapy. Cell Therapy is the cell adjustments at the molecular level. Take the chemotherapy in oncology for instance, it means to murder the cell by conveying poisonous operators to the cell, while Molecular treatments could plan to end the cell division without essentially slaughtering the cell, for example, expecting to achieve senescence whose remedial method, levels of dangerous specialists, and apparatuses for conveying the harmfulness could all be altogether different from basically executing the cell.

Track 14: Medical Diagnosis

Medical diagnosis is the way toward figuring out which illness or condition clarifies a man's side effects and signs. It is frequently alluded to as analysis with the medicinal setting being verifiable. The data required for conclusion is normally gathered from a history and physical examination of the individual looking for therapeutic care. Frequently, at least one indicative methodology, for example, analytic tests, are additionally done amid the procedure. In some cases, Posthumous finding is viewed as a sort of medicinal analysis. Finding is frequently testing, because many signs and side effects are nonspecific. For instance, redness of the skin (erythema), without anyone else's input, is an indication of many issue and in this manner, doesn't tell the human services proficient what isn't right. In this manner differential analysis, in which a few conceivable clarifications are considered, must be performed.

Track 15:Molecular Diagnostics

Molecular diagnostics is an accumulation of methods used to investigate biomarkers in the genome and proteome—the person's genetic code and how their cells express their qualities as proteins—by applying molecular biology to medicinal testing. The strategy is utilized to analyze and screen sickness, recognize chance, and choose which treatments will work best for singular patients. By dissecting the specifics of the patient and their ailment, molecular diagnostics offers the possibility of customized pharmaceutical.

Track 16: Diagnostic Genetic Testing

Research efforts involving the genetics of complex disease are rapidly progressing. Scientists have documented associations of genetic elements with many different complex disorders, such as heart disease, diabetes, mental illness, and certain cancers. However, while such studies are certainly interesting and warrant further investigation, the information derived through these efforts currently has little applicability to patient care. Since their development in the mid-1990s, DNA micro arrays have become a key tool in genetic diagnosis, allowing doctors to determine differences in gene expression between normal cells and cancerous cells, as well as to identify specific sub types of various cancers. Researchers can also use information from micro arrays to determine which treatment methods will most likely yield beneficial results for individual patients.

Track 17: Diagnosis in Nanomedicine

Nanotechnology is the designing of proficient structures at the molecular biology scale. This assures both existing work and ideas that are more imaginative in its unique sense. Nanotechnology as divided by measure is obviously extremely wide, containing fields of science as differing as surface science, natural science, molecular biology science, semiconductor material science, small scale manufacture, molecular biology designing. The related research and applications are also differing, fluctuating from expansions of customary gadget physical science to new strategies in view of sub-atomic self-get together, from rising new materials with estimations on the Nano scale to straight controller of issue on the nuclear scale.

Track 18: Diagnostic Biochemistry

Diagnosis of medical biochemistry activity plays a significant role in the Primary Health Care Center (PHCC), dominated by Family medicine and diagnostic services. Medical biochemical diagnosis has a visible place at all levels of health care, which shows the number of requests for laboratory diagnosis, number and type of required laboratory tests. There is an ever-increasing demand for improved diagnostics to support the clinicians in patient evaluation and treatment. The research in the field of clinical biochemistry has expanded, over a period, beyond traditional narrow perceptions of the discipline and evolved as a multidisciplinary activity. This is well reflected in diagnostic science and diagnostic technologies. Availability of human genome sequence and recent advances in biotechnology enabled the molecular profiling of human cells and tissues. Human diseases are better understood opening the scope for development of innovative and specific target based diagnostics.

Other Related Societies:

USA: The Association for Molecular Pathology (AMP), The American Society of Biological Chemists (ASBC) Genetics Society of America (GSA), American Society for Biochemistry and Molecular Biology (ASBMB), Society for Developmental Biology (SDB), The American Society of Human Genetics (ASHG), International Society for Computational Biology (ISCB), Genetics Society of America (GSA), American Federation for Medical Research (AFMR), Society for Redox Biology and Medicine (SFRBM), Society for Experimental Biology and Medicine (SEBM), American Society of Diagnostic and Interventional Nephrology, Society of Diagnostic Medical Sonography, Society to Improve Diagnosis in Medicine, American Society for Investigative Pathology (ASIP), American Society for Clinical Pathology, American Society for Microbiology.

Europe: The European Association of Nuclear Medicine (EANM), ESHG European Society of Human Genetics, EDMA European Diagnostic Manufacturers Association, EMBO European Molecular Biology Organization, ESGCT European Society of Gene and Cell Therapy, ICGEB International Center for Genetic Engineering and Biotechnology , FEMS Federation of European Microbiological Societies, EFB European Federation of Biotechnology , ESCMID European Society of Clinical Microbiology and Infectious Diseases, ESCV European Society for Clinical Virology, FEBS Federation of European Biochemical Societies, The European Society for Molecular Imaging, European Diagnostic Manufacturers Association, European Society of Pathology

Asia – Pacific: Chinese Society for Cell Biology (CSCB), Chinese Society of Biochemistry and Molecular Biology, The Hong Kong Society of Biochemistry and Molecular Biology, The Chinese Biological Investigator Society, Australian Society for Biochemistry and Molecular Biology, Chinese Society for Biochemistry and Molecular Biology (CSBMB), Korean Society for Biochemistry and Molecular Biology (KSBMB), The Federation of Asian and Oceanian Biochemists (FAOB), Japan Society for Molecular Science, The Genetics Society of Japan (GSJ), Fungal Molecular Biology Society of Japan, Association for Molecular Pathology (AMP), Molecular Pathology Association of India (MPAI).

Middle -East: Association for Molecular Pathology, Thailand division of International Academy of Pathology, Taiwan Society of Pathology , Indonesian Association of Clinical Pathology and Laboratory Medicine, Romanian Society of Biochemistry and Molecular Biology, Romanian Society of Human Genomics, The Malaysian Biochemical Society, Malaysian Society for Molecular Biology and Biotechnology (MSMBB).

The global market for molecular imaging devices (MID) was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.

Report Includes

· An overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward more personalized forms of treatment.

· Analyses of global market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 to 2018.

Medical Magnetic Resonance Imaging (MRI):

The global market for MRI systems was $4.9 billion in 2012. This market is projected to reach $5.4 billion in 2013 and $6.9 billion by 2018, at an estimated compound annual growth rate (CAGR) of 5% from 2013 to 2018.

Global Market Analysis For Molecular and Atomic Imaging:

This examination analyzes the worldwide market for measures used to distinguish nucleic corrosive arrangements in medicinal and life sciences applications. While the objective of all DNA-based symptomatic tests is comparable, a few distinct advancements can be utilized. Logical difficulties and advances including the most recent patterns are underscored.

We look at government controls, significant joint efforts, late licenses and factors influencing the business all inclusive. Also, we inspect new headings for DNA symptomatic advances and developing applications in clinical diagnostics.

Market Dynamics:

The expanding frequency of irresistible sicknesses, an ascent in lethal illnesses like tumor and hereditary issue, incredible prospects in the field of pharmacogenetics, expanding interest for purpose of-mind diagnostics and quickly developing innovation drive the market for atomic diagnostics. The market impediments incorporate complex administrative structure, spending imperatives, the requirement for high unpredictability testing focuses, and financial turndown.

Market Segmentation:

The sub-atomic diagnostics showcase has been fragmented by innovation, items, applications, end-clients and geology.

Innovation: In situ hybridization (ISH and FISH), chips and microarrays, mass spectroscopy, DNA sequencing (fine electrophoresis (CE) and cutting edge sequencing (NGS)), polymerase chain response (icy PCR, advanced PCR, Direct Linear™ examination, quantitative fluorescent PCR, continuous PCR, invert transcriptase PCR), quality chip and microfluidic microarrays, toxicogenomic, cytogenetics, Nano diagnostics, quality articulation based investigations, and sub-atomic imaging (optical imaging, FDG-PET).

Right now, PCR contributes the biggest offer of market income. In any case, microarrays section is relied upon to develop at the most elevated rate amid the estimate time frame.

Major Molecular Medicine Journals Globally

Journal of Community Hospital Internal Medicine Perspectives
Journal of Community Nutrition & Health
Indian Journal of Community Health
Journal of Community Health Research
Asia Pacific Family Medicine
Journal of School of Public Health and Institute of Public Health Research
AIMS Public Health
Acta Obstetrica e Ginecologia Portuguesa
African Journal of Primary Health Care & Family Medicine
Indian Journal of Community Medicine
Community Eye Health Journal
International Journal of Family Medicine
Journal of Family and Community Medicine
National Journal of Community Medicine

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	April 19-20, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View